Reproducibility, Reliability and Compliance counts
Dedicated to the development and production of highly reliable and save pharmaceutical drugs
Development and manufacturing of small molecule pharmaceuticals divides in the non-GxP part of basic research, disease discovery and drug discovery, and the GxP/FDA controlled part of drug development and manufacturing respectively. Both processes that are finely regulated and characterized by highly efficient processes, high level of automation and establishment of safety and manufacturing controls in order to provide highly reliable and save pharmaceutical drugs, biopharmaceuticals, oligonucleotides, inhalation drug products, medical devices, vaccines and regenerative medicine products to the market. As a consequence, every step from the early phase of drug development through production and quality control require constant and detailed analysis of intermediates, the final drug product and its packing material. Residual solvents (RS) and upcoming analysis of extractables and leachables (E/L) and organic volatile impurities (VOC) identification and quantification in pharmaceutical drug substances, excipients and products play a significant role for product quality where our GC, GC-MS and CDS software solutions ensure greatest reproducibility, highest reliability and full compliance to existing national and international regulations.
Our solutions for Pharmaceutical
CompassCDS is a powerful and operator friendly chromatography data system used by thousands of users around the world that brings our customer’s experience also to your desktop.